TDP-43 (TAR DNA-binding protein 43) is a nuclear RNA-binding protein that mislocalizes to the cytoplasm in ALS/FTD, forming neurotoxic aggregates. Phosphorylation at serines 409/410 (pS409/410) is a disease-specific marker. Antibodies targeting TDP-43, particularly its phosphorylated forms, are essential for diagnosing pathology, studying mechanisms, and developing therapies .
pS409/410-TDP-43 Detection: Antibodies like 26H10, 2E9, and 23A1 are critical for identifying phosphorylated TDP-43 inclusions in postmortem tissues and model systems .
ELISA and Immunoblotting: These methods quantify TDP-43 levels and phosphorylation status in patient samples, aiding in biomarker discovery .
E6 Antibody: A full-length antibody targeting the RRM1 domain reduces TDP-43 aggregation in vivo by promoting proteasomal/lysosomal degradation. It shows promise in ALS/FTLD mouse models .
Anti-pS409/410 Antibodies: Passive immunization with antibodies targeting the C-terminal domain may prevent TDP-43 phase separation and aggregation .
| Antibody | Specificity Assay | Results |
|---|---|---|
| 26H10 | ELISA (pS409/410 vs. non-phosphorylated peptides) | Strong binding to phosphorylated peptides; minimal cross-reactivity |
| E6 | Immunofluorescence (human ALS spinal cord) | Colocalizes with cytoplasmic TDP-43 aggregates |
| Model | Antibody | Outcome |
|---|---|---|
| TDP43A315T mice | E6 (intrathecal injection) | Reduced cytoplasmic TDP-43, improved motor function |
| C9orf72-G4C2 mice | Anti-pS409/410 antibodies | Moderate reduction in neuroinflammation and neuroaxonal damage |
Antibody Accessibility: Commercial pTDP-43 antibodies are costly and hard to obtain, hindering research. Initiatives like Target ALS aim to distribute validated antibodies (e.g., rabbit monoclonal pS409/410-TDP-43) to democratize access .
Immunotherapy Limitations: Full-length antibodies face challenges in crossing the blood-brain barrier. Single-chain antibodies or peptide-based therapies may offer better CNS penetration .
PER43 antibody (catalog code CSB-PA866032XA01DOA) is a polyclonal antibody that targets the PER43 protein (UniProt ID: Q9SZH2) in Arabidopsis thaliana (Mouse-ear cress) . This antibody is primarily used in plant biology research to study protein expression, localization, and function. The antibody serves as a valuable tool for investigating signaling pathways, protein-protein interactions, and developmental processes in plant systems. When designing experiments, researchers should consider the specific isoforms of PER43 they intend to detect, as different antibodies may recognize different epitopes or protein variants.
Validating antibody specificity is crucial for reliable experimental results. For PER43 antibody validation, implement these methodological approaches:
Western Blot Analysis: Run samples containing PER43 alongside negative controls (tissue where PER43 is not expressed). A specific antibody should show a single band at the expected molecular weight.
Immunoprecipitation: Perform IP with the PER43 antibody followed by mass spectrometry to confirm target enrichment.
Knockout/Knockdown Validation: Compare immunostaining patterns between wild-type and PER43 knockout/knockdown samples. Signal should be reduced or absent in knockout systems.
Peptide Competition Assay: Pre-incubate the antibody with excess PER43 peptide before immunostaining. Specific binding should be blocked.
For effective immunohistochemistry with PER43 antibody in plant tissues, follow this methodological approach:
Tissue Fixation: Fix plant tissues in 4% paraformaldehyde for 12-24 hours at 4°C.
Tissue Processing: Dehydrate samples through an ethanol series, clear with xylene, and embed in paraffin.
Sectioning: Cut 5-10 μm sections and mount on positively charged slides.
Antigen Retrieval: Perform heat-mediated antigen retrieval using citrate buffer (pH 6.0) for 20 minutes.
Blocking: Incubate sections in 5% normal serum with 0.3% Triton X-100 for 1 hour at room temperature.
Primary Antibody: Dilute PER43 antibody 1:200-1:500 in blocking solution and incubate overnight at 4°C.
Detection: Use an appropriate secondary antibody system (HRP or fluorescence-based) and visualize according to manufacturer protocols.
Controls: Always include negative controls (primary antibody omitted) and positive controls (tissues known to express PER43).
Plant tissues require special consideration for cell wall permeabilization and autofluorescence reduction compared to animal tissues.
To maintain optimal activity of PER43 antibody, follow these evidence-based storage guidelines:
Short-term Storage: Store at 4°C for up to two weeks. Avoid repeated freeze-thaw cycles.
Long-term Storage: Store at -20°C in small aliquots (10-50 μL) to prevent repeated freeze-thaw cycles.
Buffer Conditions: The antibody should be stored in buffer containing stabilizers such as glycerol (50%) and protein stabilizers.
Contamination Prevention: Use sterile techniques when handling antibody solutions to prevent microbial contamination.
Temperature Fluctuations: Avoid temperature fluctuations during storage and transport.
Research has shown that antibody activity can decrease by up to 50% after 5 freeze-thaw cycles, emphasizing the importance of proper aliquoting and storage protocols.
When working with PER43 antibody (UniProt ID: Q9SZH2), researchers should consider these cross-reactivity factors:
Homologous Proteins: PER43 may share sequence similarity with other members of its protein family, potentially causing cross-reactivity.
Species Cross-Reactivity: While PER43 antibody is designed for Arabidopsis thaliana, it may cross-react with homologous proteins in closely related plant species .
Isoform Specificity: Determine whether the antibody recognizes all isoforms or specific variants of the target protein.
Epitope Masking: Consider whether post-translational modifications might mask the epitope in certain experimental conditions.
To address these concerns, perform these validation steps:
Test the antibody in tissues/cells known to lack PER43 expression
Use western blot analysis to confirm band specificity
Consider peptide competition assays to validate specificity
For comparing PER43 expression across developmental stages, implement this methodological framework:
| Technique | Sample Preparation | Analysis Method | Controls |
|---|---|---|---|
| Western Blot | Extract proteins from tissues at different stages using identical protocols | Quantify band intensity normalized to loading controls | Include tissue-specific negative controls |
| qRT-PCR | Extract RNA using standardized methods with DNase treatment | Calculate relative expression using ΔΔCt method | Use multiple reference genes (e.g., ACTIN2, UBQ10) |
| Immunohistochemistry | Process tissues from different stages simultaneously | Quantify signal intensity using identical imaging parameters | Include isotype controls for each developmental stage |
Key considerations for experimental design:
Use plants grown under identical environmental conditions
Sample at precisely defined developmental stages
Process all samples in parallel to minimize technical variation
Include biological replicates (minimum n=3) for statistical validity
Perform time-course experiments rather than endpoint analysis for dynamic processes
Optimizing PER43 antibody dilution requires systematic titration across different applications:
Western Blot Optimization:
Start with manufacturer's recommended dilution (typically 1:1000)
Prepare a dilution series (1:500, 1:1000, 1:2000, 1:5000)
Evaluate signal-to-noise ratio and specificity at each dilution
Select dilution that provides clear specific signal with minimal background
Immunohistochemistry/Immunofluorescence Optimization:
Begin with higher concentrations (1:100-1:500)
Test multiple fixation and antigen retrieval methods
For plant tissues, test different cell wall digestion protocols
Evaluate signal intensity, background, and specificity
ELISA Optimization:
Create a broad dilution series (1:100 to 1:10,000)
Generate standard curves with known antigen concentrations
Calculate signal-to-noise ratios at each dilution
Select dilution in the linear range of detection
Remember that optimal dilutions may vary between different tissue types and experimental conditions. Document optimization experiments thoroughly for reproducibility.
When experiencing weak or absent PER43 antibody signal in western blots, systematically troubleshoot using this decision tree approach:
Sample Preparation Issues:
Ensure complete protein extraction using plant-specific extraction buffers containing proper detergents
Add protease inhibitors freshly before extraction
Confirm protein concentration using Bradford or BCA assay
Avoid sample degradation by keeping samples cold and processing quickly
Protein Transfer Problems:
Verify transfer efficiency with reversible staining (Ponceau S)
Optimize transfer conditions for PER43's molecular weight
For plant proteins, consider extended transfer times due to cell wall components
Use PVDF membranes for higher protein binding capacity
Antibody-Related Issues:
Test fresh antibody aliquot to rule out degradation
Increase antibody concentration (use 2-5× higher concentration)
Extend primary antibody incubation time (overnight at 4°C)
Try different blocking agents (BSA vs. non-fat milk)
Detection System Problems:
Use more sensitive detection reagents
Increase exposure time
Consider signal amplification systems
Check secondary antibody reactivity and concentration
If the problem persists, perform positive control experiments with tissues/cells known to express high levels of PER43 to validate antibody functionality.
Non-specific binding with PER43 antibody can be addressed through these methodological interventions:
Blocking Optimization:
Test different blocking agents (5% BSA, 5% non-fat milk, commercial blockers)
Extend blocking time to 2 hours at room temperature
Add 0.1-0.3% Tween-20 to blocking buffer
For plant samples, consider adding plant-derived blocking agents
Washing Protocol Enhancement:
Increase number of wash steps (5-6 washes of 5-10 minutes each)
Use higher concentrations of detergent in wash buffer (0.1-0.5% Tween-20)
Perform washing steps with larger volumes of buffer
Include salt gradient washes to disrupt low-affinity interactions
Antibody Dilution Refinement:
Use higher dilutions of primary antibody
Prepare antibody solution in blocking buffer
Pre-absorb antibody with proteins from non-target tissues
Consider affinity purification of the antibody
Sample Preparation Improvements:
Include additional purification steps
Use more stringent extraction conditions
Remove potential cross-reactive components
For plant tissues, consider additional steps to remove phenolic compounds
Each of these approaches should be tested systematically, changing one variable at a time and documenting the outcomes.
For effective use of PER43 antibody in ChIP experiments with plant samples, follow this specialized protocol:
Crosslinking Optimization:
Test different formaldehyde concentrations (1-3%) and crosslinking times (10-20 minutes)
For plant tissues, consider vacuum infiltration to ensure even fixation
Quench with glycine (final concentration 0.125 M)
Chromatin Preparation:
Grind tissue in liquid nitrogen to fine powder
Use plant-specific nuclei isolation buffers
Sonicate to achieve fragments of 200-500 bp (verify by agarose gel)
Remove cell wall debris with multiple centrifugation steps
Immunoprecipitation:
Pre-clear chromatin with protein A/G beads
Use 2-5 μg PER43 antibody per immunoprecipitation
Include appropriate controls (IgG control, input samples)
Extend incubation time to 16 hours at 4°C with rotation
Washing and Elution:
Use increasingly stringent wash buffers
Perform multiple washes (4-6) for each buffer
Elute DNA-protein complexes at 65°C
Reverse crosslinks overnight at 65°C
Data Analysis:
Perform qPCR with primers targeting potential binding regions
Calculate percent input or fold enrichment
Include positive control regions and negative control regions
Consider ChIP-seq for genome-wide binding analysis
This protocol addresses the specific challenges of plant ChIP experiments, including cell wall interference and high levels of secondary metabolites.
For successful co-immunoprecipitation (co-IP) studies with PER43 antibody in plant systems, consider these critical factors:
Lysis Buffer Optimization:
Test different detergent types and concentrations (NP-40, Triton X-100, digitonin)
Adjust salt concentration to maintain protein-protein interactions
Include protease and phosphatase inhibitors
For plant samples, add compounds to sequester phenolics and polysaccharides
Antibody Coupling Strategies:
Direct coupling to beads (covalent) vs. indirect capture
For PER43 antibody, test both Protein A and Protein G beads
Consider crosslinking antibody to beads to prevent co-elution
Determine optimal antibody amount through titration
Experimental Controls:
IgG control from same species as PER43 antibody
Input sample (5-10% of starting material)
Reciprocal co-IP with antibodies against suspected interaction partners
Negative controls using tissues lacking PER43 expression
Elution and Analysis Methods:
Compare different elution conditions (pH, competitive elution, SDS)
Analyze by western blot or mass spectrometry
For novel interactions, confirm with orthogonal methods
Consider size exclusion chromatography to preserve native complexes
Table: Comparison of Co-IP Approaches for PER43 in Plant Systems
| Method | Advantages | Limitations | Best For |
|---|---|---|---|
| Standard Co-IP | Simple setup, widely established | May miss weak interactions | Confirming suspected interactions |
| Crosslinked Co-IP | Captures transient interactions | May introduce artifacts | Detecting weak/transient interactions |
| Tandem Affinity Purification | High specificity, low background | Requires tagged protein | Mapping comprehensive interactomes |
| Proximity-Based Labeling | Captures in vivo interactions | Requires genetic modification | In vivo interaction networks |
For robust quantification and normalization of PER43 expression from immunoblot analyses, follow these evidence-based practices:
Image Acquisition:
Capture images within the linear dynamic range of the detection system
Use the same exposure settings for all samples
Avoid saturated pixels that compromise quantification
Include a dilution series of one sample to verify linearity
Quantification Methods:
Use densitometry software (ImageJ, Image Lab, etc.)
Define regions of interest consistently across lanes
Subtract background using lane-specific or global methods
Generate integrated density values rather than peak heights
Normalization Strategies:
Use multiple loading controls (housekeeping proteins)
For plant samples, consider RuBisCO as a potential loading control
Verify that loading controls are not affected by experimental conditions
Calculate relative expression as (PER43 signal/loading control signal)
Statistical Analysis:
Perform experiments with at least three biological replicates
Apply appropriate statistical tests (t-test, ANOVA)
Report both mean values and measures of variability
Consider using non-parametric tests if assumptions of normality are violated
Visualization Methods:
Present both representative blot images and quantitative graphs
Include error bars representing standard deviation or standard error
Indicate statistical significance on graphs
Use consistent scaling across comparable datasets
To evaluate the quality and reliability of PER43 antibody-generated data for publication, implement these rigorous validation steps:
Antibody Validation Documentation:
Include complete information about the antibody (catalog number, lot number, dilution)
Document specificity tests performed (western blot, peptide competition)
Cite previous publications that have validated this antibody
Provide evidence of knockout/knockdown controls if available
Technical Quality Assessment:
Evaluate signal-to-noise ratio in all experimental outcomes
Confirm reproducibility across biological and technical replicates
Verify that controls behave as expected
Ensure all bands/signals are within the linear range of detection
Biological Validity Assessment:
Compare results with existing literature on PER43
Confirm that expression patterns match known biology
Validate key findings with orthogonal methods
Address any discrepancies with previous studies
Quantitative Rigor:
Apply appropriate statistical analyses
Report all replicates and experimental details
Include raw data and unprocessed images as supplementary materials
Follow field-specific reporting guidelines (e.g., ARRIVE for animal studies)
Table: Quality Control Checklist for PER43 Antibody Data
| Aspect | Quality Indicators | Red Flags |
|---|---|---|
| Specificity | Single band at expected MW, signal absent in negative controls | Multiple bands, signal in negative controls |
| Reproducibility | Consistent results across replicates | High variability between experiments |
| Controls | All controls perform as expected | Missing controls, unexpected control results |
| Signal Quality | Clear signal with low background | High background, weak specific signal |
| Quantification | Data within linear range, appropriate normalization | Saturated signals, inappropriate normalization |
| Statistical Analysis | Appropriate tests, sufficient sample size | Incorrect statistical methods, insufficient replication |
For integrating PER43 antibody into mass spectrometry-based proteomics workflows, implement this specialized methodology:
Immunoprecipitation-Mass Spectrometry (IP-MS):
Perform IP with PER43 antibody using IP buffer compatible with MS
Elute proteins with minimal detergents and salts
Digest eluted proteins with trypsin following standard protocols
Analyze by LC-MS/MS using data-dependent acquisition
Antibody-Based Protein Complex Purification:
Crosslink PER43 antibody to magnetic beads
Capture PER43 and associated proteins from plant lysates
Optimize washing to reduce background while maintaining interactions
Process samples for either bottom-up or native MS approaches
Selected Reaction Monitoring (SRM) Assay Development:
Use immunoprecipitated PER43 to identify proteotypic peptides
Develop targeted MS assays for quantification
Create internal standard peptides for absolute quantification
Validate assay specificity and sensitivity
Post-Translational Modification Analysis:
Enrich PER43 using the antibody
Apply specific enrichment strategies for PTMs of interest
Analyze by MS with ETD or HCD fragmentation
Map modifications to protein domains using database searches
Spatial Proteomics Applications:
Combine immunofluorescence with laser capture microdissection
Isolate PER43-positive regions for MS analysis
Compare protein expression in different subcellular compartments
Correlate MS data with microscopy observations
These approaches enable detailed characterization of PER43's interactome, modifications, and dynamics in plant systems.
When applying PER43 antibody in super-resolution microscopy of plant samples, consider these critical technical factors:
Sample Preparation Optimization:
Test different fixation protocols (paraformaldehyde, glutaraldehyde, or combinations)
Optimize cell wall digestion for plant tissues (pectinase, cellulase treatments)
Use thinner sections (70-100 nm for STORM/PALM)
Mount samples on high-precision coverslips for optimal imaging
Antibody Selection and Labeling:
Use highly purified PER43 antibody preparations
For direct STORM, conjugate antibody with appropriate fluorophores (Alexa 647, Cy5)
For PALM, consider genetic fusion with photoactivatable fluorescent proteins
For dual-color imaging, ensure minimal cross-talk between channels
Imaging Parameters:
Determine optimal buffer conditions for fluorophore photoswitching
Adjust laser power to balance signal intensity and photobleaching
Optimize camera settings (exposure time, EM gain)
Collect sufficient localizations for reconstruction (typically >10^6)
Controls and Validation:
Include fiducial markers for drift correction
Perform two-color controls with known structures
Validate resolution using structures of known dimensions
Compare with conventional microscopy to ensure biological relevance
Analysis Considerations:
Apply appropriate reconstruction algorithms
Perform cluster analysis for protein distribution
Quantify co-localization using coordinate-based methods
Correlate super-resolution data with functional assays
By addressing these considerations, researchers can achieve nanoscale visualization of PER43 localization and interactions in plant cellular contexts, revealing details not accessible with conventional microscopy.
For incorporating PER43 antibody into single-cell protein analysis of plant systems, consider these innovative methodological approaches:
Single-Cell Immunofluorescence Profiling:
Isolate individual plant cells through protoplasting or mechanical dissociation
Perform fixation and permeabilization optimized for single cells
Use PER43 antibody with fluorescent detection
Analyze using high-content imaging systems or flow cytometry
Correlate with cell type-specific markers
Mass Cytometry (CyTOF) Applications:
Conjugate PER43 antibody with rare earth metals
Combine with other metal-labeled antibodies for multiplexed detection
Analyze dissociated plant cells using mass cytometry
Apply dimensionality reduction techniques (tSNE, UMAP) for visualization
Identify cell populations with distinct PER43 expression patterns
Microfluidic Antibody Capture Techniques:
Design microfluidic chambers for single plant cell capture
Implement on-chip immunoassays with PER43 antibody
Use droplet-based systems for high-throughput analysis
Combine with single-cell transcriptomics for multi-omic profiling
Proximity Ligation Assays at Single-Cell Level:
Apply in situ proximity ligation with PER43 antibody and interaction partners
Quantify interaction events in individual cells
Analyze spatial distribution of interactions
Correlate with cellular phenotypes
Table: Comparison of Single-Cell Protein Analysis Methods for PER43
| Method | Throughput | Resolution | Multiplexing Capacity | Best Application |
|---|---|---|---|---|
| Single-Cell IF | Medium | Subcellular | 4-10 proteins | Spatial localization studies |
| Mass Cytometry | High | Cellular | 40+ proteins | Population heterogeneity analysis |
| Microfluidic Assays | Medium-High | Cellular | 5-15 proteins | Secretion and signaling studies |
| Single-Cell Western | Low-Medium | Protein isoforms | 3-5 proteins | Isoform-specific analysis |
These approaches enable unprecedented insights into cell-to-cell variability in PER43 expression and function within plant tissues.
For using PER43 antibody in plant tissue clearing and 3D imaging, consider these specialized methodological factors:
Tissue Clearing Protocol Selection:
Evaluate different clearing methods for plant tissues (CLARITY, ClearSee, PEA-CLARITY)
Optimize clearing time based on tissue thickness and density
Adjust protocols to account for plant-specific structures (cell walls, plastids)
Test antibody compatibility with clearing reagents
Antibody Penetration Strategies:
Extend antibody incubation times (3-7 days) for thick specimens
Apply higher antibody concentrations than used for thin sections
Consider using smaller antibody fragments (Fab, nanobodies) for better penetration
Use active transport methods (centrifugation, pressure) to enhance penetration
3D Imaging Optimization:
Select appropriate objectives for large working distances
Optimize laser power and detection settings for each tissue depth
Implement z-correction for signal attenuation
Use adaptive optics to correct for scattering and aberrations
Image Processing and Analysis:
Apply deconvolution algorithms to improve signal-to-noise ratio
Implement 3D segmentation for quantitative analysis
Use registration techniques to align multi-channel datasets
Apply specialized software for large dataset visualization and analysis
Validation Approaches:
Compare with traditional section-based immunohistochemistry
Perform multi-angle imaging to confirm complete antibody penetration
Include depth-dependent controls to assess staining uniformity
Verify findings with orthogonal methods
By addressing these considerations, researchers can achieve comprehensive 3D visualization of PER43 distribution in intact plant tissues, revealing spatial relationships not observable in traditional thin-section approaches.
Several emerging technologies and approaches are poised to enhance PER43 antibody applications in plant research:
Next-Generation Recombinant Antibodies:
Development of single-domain antibodies (nanobodies) against PER43
Creation of recombinant antibodies with improved specificity and reduced batch variation
Engineering of bifunctional antibodies for simultaneous detection of PER43 and interaction partners
Production of antibodies targeting specific PER43 post-translational modifications
Advanced Imaging Technologies:
Integration with expansion microscopy for improved resolution
Combined with light-sheet microscopy for rapid whole-organ imaging
Application in correlative light and electron microscopy (CLEM)
Implementation in live-cell imaging through cell-permeable antibody derivatives
High-Throughput and Automation:
Development of automated immunostaining platforms for plants
Integration with robotics for large-scale screening applications
Creation of microarray-based antibody platforms for plant proteomics
Implementation in automated phenotyping platforms
Computational and AI Approaches:
Machine learning algorithms for improved image analysis
Automated pattern recognition for protein localization
Integration of antibody-derived data with multi-omics datasets
Predictive modeling of protein dynamics based on antibody-generated data
These advancements will facilitate more comprehensive understanding of PER43's role in plant biology through improved sensitivity, specificity, throughput, and integration with complementary technologies.
To enhance reproducibility when using PER43 antibody across different studies, implement these systematic approaches:
Standardized Reporting:
Document complete antibody information (supplier, catalog number, lot number, RRID)
Report detailed methods including dilutions, incubation times, and temperatures
Include all validation steps performed
Share raw, unprocessed data alongside analyzed results
Validation Standards:
Establish community-agreed validation criteria for PER43 antibody
Perform multiple validation methods (western blot, immunoprecipitation, knockout controls)
Share validation data in public repositories
Validate across different experimental conditions and plant growth stages
Reference Materials and Controls:
Develop standard reference samples for antibody testing
Create shared positive and negative control materials
Establish calibration standards for quantitative applications
Implement spike-in controls for normalization
Collaborative Approaches:
Participate in multi-laboratory validation studies
Contribute to antibody validation databases
Engage in reagent sharing programs
Implement round-robin testing of critical findings
Table: Reproducibility Enhancement Checklist for PER43 Antibody Research
| Phase | Key Actions | Documentation Requirements |
|---|---|---|
| Experimental Design | Power analysis, blinding, randomization | Preregistration, detailed protocols |
| Antibody Selection | Validation testing, lot testing | Validation results, antibody metadata |
| Method Implementation | Protocol optimization, quality controls | Detailed methods, control outcomes |
| Data Analysis | Predefined analysis plans, appropriate statistics | Analysis code, raw data |
| Reporting | Complete methods, all results | Comprehensive methods, supplementary data |